MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals (ASX:CXS) (NASDAQ:CXSP) today announced that Dr. Julie Cherrington, President of Phenomix Corporation, has joined the company’s Board of Directors. Dr. Cherrington is an experienced senior executive with an outstanding record in research management, clinical development and corporate activities, with more than 25 years experience in research, biotechnology, and the pharmaceutical industry.
